Shah ND - Search Results

1

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD.

Dibba P, Li AA, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Dibba P, et al. Among authors: shah nd. Diseases. 2018 Sep 19;6(3):83. doi: 10.3390/diseases6030083. Diseases. 2018. PMID: 30235807 Free PMC article. Review.

2

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD.

Perumpail BJ, Li AA, Iqbal U, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Perumpail BJ, et al. Among authors: shah nd. Diseases. 2018 Sep 10;6(3):80. doi: 10.3390/diseases6030080. Diseases. 2018. PMID: 30201879 Free PMC article. Review.

3

Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis.

Farooqui MT, Khan MA, Cholankeril G, Khan Z, Mohammed Abdul MK, Li AA, Shah N, Wu L, Haq K, Solanki S, Kim D, Ahmed A. Farooqui MT, et al. Eur J Gastroenterol Hepatol. 2019 Feb;31(2):149-156. doi: 10.1097/MEG.0000000000001263. Eur J Gastroenterol Hepatol. 2019. PMID: 30234644 Free PMC article.

4

The Role of Vitamin E in the Treatment of NAFLD.

Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Perumpail BJ, et al. Among authors: shah nd. Diseases. 2018 Sep 24;6(4):86. doi: 10.3390/diseases6040086. Diseases. 2018. PMID: 30249972 Free PMC article. Review.

5

Judicious Use of Lipid Lowering Agents in the Management of NAFLD.

Iqbal U, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Iqbal U, et al. Among authors: shah nd. Diseases. 2018 Sep 24;6(4):87. doi: 10.3390/diseases6040087. Diseases. 2018. PMID: 30249980 Free PMC article. Review.

6

When to Initiate Weight Loss Medications in the NAFLD Population.

Yoo ER, Sallam S, Perumpail BJ, Iqbal U, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Yoo ER, et al. Among authors: shah nd. Diseases. 2018 Sep 30;6(4):91. doi: 10.3390/diseases6040091. Diseases. 2018. PMID: 30274326 Free PMC article. Review.

7

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD.

Cholankeril R, Patel V, Perumpail BJ, Yoo ER, Iqbal U, Sallam S, Shah ND, Kwong W, Kim D, Ahmed A. Cholankeril R, et al. Among authors: shah nd. Diseases. 2018 Oct 3;6(4):93. doi: 10.3390/diseases6040093. Diseases. 2018. PMID: 30282916 Free PMC article. Review.

8

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD.

Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Perumpail BJ, et al. Among authors: shah nd. Diseases. 2019 Feb 25;7(1):27. doi: 10.3390/diseases7010027. Diseases. 2019. PMID: 30823570 Free PMC article. Review.

9

Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations.

Dennis BB, Sallam S, Perumpail BJ, Shah ND, Kim D, Cholankeril G, Ahmed A. Dennis BB, et al. Among authors: shah nd. J Clin Gastroenterol. 2021 Oct 1;55(9):747-756. doi: 10.1097/MCG.0000000000001555. J Clin Gastroenterol. 2021. PMID: 34469404 Review.

10

Exclusive Yet Effective: The Crohn's Disease Exclusion Diet as Treatment for Medication-Refractory Disease.

Field J, Shah ND, Memel Z, Mahadevan U, Beck K. Field J, et al. Among authors: shah nd. Dig Dis Sci. 2024 Mar 30. doi: 10.1007/s10620-024-08345-5. Online ahead of print. Dig Dis Sci. 2024. PMID: 38555328 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

580 results

Search Page